BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, November 23, 2024
See today's BioWorld
Home
» Year in Review: Second best VC financings year overall, 2019 rises to top with seed, series B rounds
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Year in Review: Second best VC financings year overall, 2019 rises to top with seed, series B rounds
Dec. 30, 2019
By
Karen Carey
No Comments
While the number of venture capital financings are continuing the upward trend begun in 2018, amounts raised are down from last year, aside from series B rounds that have brought in 28% more in funds of $5.49 billion.
BioWorld
Financings